Gilead Sciences Ownership | Who Owns Gilead Sciences?


OverviewForecastRevenueFinancialsChartTranscripts

Gilead Sciences Ownership Summary


Gilead Sciences is owned by 0.42% institutional investors, 0.12% insiders, and 99.45% retail investors. Blackrock is the largest institutional shareholder, holding 9.67% of GILD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.22% of its assets in Gilead Sciences shares.

GILD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGilead Sciences0.42%0.12%99.45%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryDrug Manufacturers - General Stocks37.59%1.26%61.15%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock120.63M9.67%$8.28B
Blackrock funding, inc. /de120.36M9.65%$11.12B
Vanguard group115.53M9.26%$10.67B
Capital world investors71.71M5.75%$6.62B
State street59.33M4.76%$4.07B
Capital research global investors57.95M4.65%$5.35B
Fmr40.32M3.23%$3.72B
Wellington management group llp35.66M2.86%$3.29B
Dodge & cox32.95M2.64%$3.04B
Geode capital management28.29M2.27%$2.61B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sector gamma as197.50K6.27%$18.24M
Mccarthy asset management130.36K5.27%$8.94M
Parkman healthcare partners374.82K4.61%$34.62M
Westend capital management138.64K3.80%$12.81M
F&v capital management155.33K3.78%$14.35M
Twin lakes capital management76.21K3.57%$5.23M
Foundation resource management207.72K3.20%$19.19M
Verity & verity378.10K3.19%$34.93M
Globeflex capital l p404.61K3.17%$37.37M
Sofinnova investments418.90K3.07%$46.94M

Top Buyers

HolderShares% AssetsChange
Norges bank19.37M0.23%19.37M
Fmr40.32M0.22%7.16M
Pacer advisors6.43M1.28%5.65M
Bank of new york mellon16.76M0.30%2.83M
Raymond james financial2.24M0.08%2.24M

Top Sellers

HolderShares% AssetsChange
Citadel advisors278.39K0.00%-5.04M
Capital world investors71.71M1.01%-4.84M
Capital research global investors57.95M1.10%-3.85M
Arrowstreet capital, limited partnership139.61K0.01%-2.86M
Voloridge investment management---2.38M

New Positions

HolderShares% AssetsChangeValue
Norges bank19.37M0.23%19.37M$1.79B
Raymond james financial2.24M0.08%2.24M$207.34M
Adage capital partners gp1.71M0.28%1.71M$158.33M
Masters capital management385.00K1.49%385.00K$26.41M
Proficio capital partners339.49K0.03%339.49K$339.49K

Sold Out

HolderChange
Hoey investments-2.00
Mendota financial group-3.00
Country trust bank-3.00
Kohmann bosshard financial services-4.00
Cypress capital management llc (wy)-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202519-99.01%5,280,450-99.50%-0.01%7-99.24%5-99.30%
Dec 31, 20241,238-29.82%522,772,791-49.04%410.62%590-25.69%468-31.68%
Sep 30, 20241,7401.05%1,025,105,383-1.03%821.19%7841.69%673-0.30%
Jun 30, 20241,691-3.92%1,032,995,9351.04%821.23%7591.61%663-9.80%
Mar 31, 20241,760-3.40%1,022,412,986-1.81%811.18%747-14.14%7356.99%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv40.02M3.22%34.82K
Vanguard US Total Market Shares ETF39.45M3.17%28.77K
Vanguard Institutional 500 Index Trust35.44M2.85%245.78K
Invesco QQQ Trust25.67M2.06%-124.50K
Dodge & Cox Stock I22.94M1.84%-1.41M
American Funds Income Fund of Amer A19.87M1.60%-4.12M
Fidelity 500 Index15.72M1.26%68.31K
SPDR® S&P 500 ETF15.51M1.25%-227.69K
SPDR® S&P 500® ETF Trust15.10M1.21%-79.06K
SPDR® S&P 500® ETF15.00M1.21%-52.70K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 15, 2025Mercier Johanna Chief Commercial OfficerSell$333.09K
Jul 15, 2025Dickinson Andrew D Chief Financial OfficerSell$277.57K
Jul 14, 2025Bluestone Jeffrey-Sell$548.70K
Jun 30, 2025O'Day Daniel Patrick Chairman & CEOSell$66.69K
Jun 30, 2025O'Day Daniel Patrick Chairman & CEOSell$1.04M

Insider Transactions Trends


DateBuySell
2025 Q3-3
2025 Q2-11
2025 Q1-7
2024 Q4-13
2024 Q3-6

GILD Ownership FAQ


Who Owns Gilead Sciences?

Gilead Sciences shareholders are primarily institutional investors at 0.42%, followed by 0.12% insiders and 99.46% retail investors. The average institutional ownership in Gilead Sciences's industry, Drug Manufacturers - General Stocks, is 37.59%, which Gilead Sciences falls below.

Who owns the most shares of Gilead Sciences?

Gilead Sciences’s largest shareholders are Blackrock (120.63M shares, 9.67%), Blackrock funding, inc. /de (120.36M shares, 9.65%), and Vanguard group (115.53M shares, 9.26%). Together, they hold 28.59% of Gilead Sciences’s total shares outstanding.

Does Blackrock own Gilead Sciences?

Yes, BlackRock owns 9.67% of Gilead Sciences, totaling 120.63M shares as of Jun 2024. This represents 0.19% of BlackRock's total assets, with a market value of 8.28B$. In the last quarter, BlackRock decreased its holdings by -1.899M shares, a -1.55% change.

Who is Gilead Sciences’s biggest shareholder by percentage of total assets invested?

Sector gamma as is Gilead Sciences’s biggest shareholder by percentage of total assets invested, with 6.27% of its assets in 197.5K Gilead Sciences shares, valued at 18.24M$.

Who is the top mutual fund holder of Gilead Sciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Gilead Sciences shares, with 3.22% of its total shares outstanding invested in 40.02M Gilead Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools